NANO-X IMAGING LTD Ordinary Shares
NNOXNano-X Imaging Ltd is a medical imaging company that develops and commercializes advanced digital X-ray systems. Known for its proprietary Nanox.ARC platform, the company aims to provide affordable, high-quality imaging solutions globally, particularly in underserved healthcare markets. Nano-X focuses on innovative technology to transform medical imaging and improve patient care accessibility.
Company News
Rosen Law Firm has filed class action lawsuits against GPGI, Inc. (formerly CompoSecure), Lucid Group, Inc., and Nano-X Imaging Ltd. on behalf of investors who suffered losses. The GPGI lawsuit alleges defendants made materially false statements regarding the Husky acquisition valuation and financial targets. Investors are encouraged to secure co...
Rosen Law Firm is reminding investors who purchased Nano-X Imaging Ltd. securities between March 31, 2025 and April 17, 2026 of an important August 11, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Nano-X made false statements about operational efficiency and product demand, while concealing poor man...
A class action lawsuit has been filed against Nano-X Imaging Ltd. (NASDAQ: NNOX) alleging that company executives made materially false and misleading statements regarding operational efficiency and product demand. The complaint claims Nano-X overstated efficiency gains while concealing poor alignment between production and demand, leading to inc...
Nano-X Imaging Ltd. (NNOX) investors have until August 11, 2026, to file motions to become lead plaintiffs in a securities class action lawsuit. The action stems from a 24.39% single-day stock decline on April 20, 2026, following disclosure of a $17.5 million asset impairment and closure of the company's South Korean chip manufacturing facility. ...
Rosen Law Firm is urging investors who purchased Nano-X Imaging Ltd. securities between March 31, 2025 and April 17, 2026 to join a class action lawsuit. The lawsuit alleges that Nano-X made false statements about operational efficiency and product demand, while concealing poor manufacturing alignment, increased operating expenses, and significan...
